Expert Insights
Obesity Management Strategies That Can Reap the Benefits of Long-term Weight Loss
Release Date: October 29, 2021
Expiration Date: October 28, 2022
CE/CME Credit Hours: 1.00
Pharmacology Credit Hours: 1.00
Begin »
Program Overview
Program Description
As understanding of its underlying pathophysiology has deepened, the fact that obesity is a disease—and not a personal failing—has been incorporated into guidelines and medical language. Both the American Medical Association and American Association of Clinical Endocrinologists recognize obesity as a disease characterized by multiple pathophysiologic aspects and requiring a range of interventions for treatment and prevention. Incretin-based treatment for obesity has become an area of keen interest in recent years. An understanding of the metabolic underpinnings of obesity coupled with knowledge of current and emerging incretin-based therapies will assist healthcare professionals in successful treatment of patients with obesity over the long term. This activity provides expert insights about available and emerging treatment advances for obesity that will help patients achieve long-term weight loss and associated health benefits.
Format
eNewsletter with interactive benchmarking and video commentary
Learning Objectives
After completing this activity, participants should be better able to:
- Evaluate patients with obesity for common related diseases including type 2 diabetes, cardiovascular disease, dyslipidemia, and fatty liver disease
- Detail evidence that supports the benefits of maintaining a healthy weight to reduce risk of cardiometabolic complications
- Apply incretin-based strategies for long-term weight maintenance
Target Audience
NPs and PAs
Faculty
Fatima Cody Stanford, MD, MPH, MPA, MBA
- Obesity Medicine Physician Scientist
- Departments of Medicine and Pediatrics
- Harvard Medical School
- Divisions of Neuroendocrine and Pediatric Endocrinology
- Massachusetts General Hospital
- Boston, Massachusetts
Details
Joint Accreditation Statement
In support of improving patient care, Practicing Clinicians Exchange is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
ANCC Credit Designation
CNE course advisor: Mary Knudtson, DNSc, NP, FAAN, University of California, Irvine, Irvine, California
Nursing contact hours: 1.00, which includes 1.00 hours of pharmacology credit
AAPA Credit Designation
Practicing Clinicians Exchange has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credit. Approval is valid until October 28, 2022. PAs should only claim credit commensurate with the extent of their participation.
PA course advisor: Jennifer Wohl, DHSc, PA-C, Eastern Virginia Medica School, Norfolk, Virginia
IPCE Credit Designation
This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education (IPCE) credit for learning and change.
This program was cosupported by educational grants from AbbVie Inc.; Astellas; Genentech, a member of the Roche Group; Novo Nordisk; Regeneron; and Urovant Sciences, Inc.
This activity is supported by an educational grant from Novo Nordisk.
Practicing Clinicians Exchange gratefully acknowledges Clinical Care Options (CCO) for their contributions as an educational partner for this program.
The opinions or views expressed in this CE/CME activity do not necessarily reflect the opinions or recommendations of Practicing Clinicians Exchange or any educational supporter.
All faculty and planners participating in continuing education activities sponsored by Practicing Clinicians Exchange (PCE) are required to disclose to the audience all financial relationships with ineligible companies. All relevant conflicts of interest are thoroughly vetted and mitigated according to PCE policy. In addition, all faculty are required to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in this activity. The faculty and Planning Committee have been advised that this activity must be free from commercial bias and based upon all available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.
Dr Stanford: consulting fees: Calibrate, Novo Nordisk.
None of the members of the Planning Committee or PCE staff have any relevant relationships to disclose.
Participants wishing to earn CE/CME credit must:
- Review the content in its entirety
- Relate the content material to the learning objectives
- Complete the post-test and evaluation form
Successful completion of the post-test is required to earn CE/CME credit. Successful completion is defined as a cumulative score of at least 67%.
The estimated time to complete this activity is 1.00 hour.
Release date: October 29, 2021
Expiration date: October 28, 2022
For Practicing Clinicians Exchange general information, contact pce@practicingclinicians.com.
© 2021 Practicing Clinicians Exchange. All Rights Reserved. 102221C-7A